Johnson & Johnson (J&J) is asking regulatory authorities in the European Union to approve a combination treatment based on…
Articles by Marisa Wexler, MS
A single infusion of the CAR T-cell therapy Carvykti (ciltacabtagene autoleucel) was sufficient to control disease activity in most…
Arcellx and Kite Pharma are planning to launch a Phase 3 clinical trial, dubbed iMMagine-3, to…
At its 15th annual gala, held in New York City this April, the International Myeloma Foundation (IMF) raised more…
A dysregulated immune response against viruses that cause hepatitis may lead to some cases of multiple myeloma (MM) —…
Adding Darzalex Faspro (daratumumab and hyaluronidase) — a subcutaneous or under-the-skin formulation of Darzalex (daratumumab) — to a standard…
The U.S. Food and Drug Administration (FDA) is delaying its review of an application that seeks to allow the cell…
A committee of the European Medicines Agency (EMA) has recommended that Elrexfio (elranatamab) — a therapy already in use…
While diabetes is more frequent among Black people than white people, it’s associated with poorer survival outcomes in white people…
People with hard-to-treat multiple myeloma given a regimen of Venclexta (venetoclax) plus dexamethasone lived longer than those treated with…